Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rajasthan Plans End To India Policy Dependence For Open Market

This article was originally published in PharmAsia News

Executive Summary

The head of Rajasthan Drugs and Pharmaceuticals says the company has benefited greatly by India's 2006 policy to cover 102 drugs made by central public-sector undertakings. Managing Director R.K. Vashishtha said Rajasthan's gain also was shared by other COSUs, which were given five years of automatic coverage by the government, public sector enterprises and non-government organizations. For Rajasthan, that has led to a large numbers of orders for its drugs, and the company now seeks to enter the open market with its products, eventually becoming self-reliant. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts